Last kr5.05 SEK
Change Today +0.05 / 1.00%
Volume 690.7K
As of 11:29 AM 12/18/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

Karolinska Institutet Science Park

Banvaktsvägen 22

Solna, 171 48

Sweden

Phone: 46 8 50 12 60 80

Fax:

Kancera AB, a biotechnology company, engages in the development and sale of drug candidates that cure or stop the progression of cancer. Its pharmaceutical development projects include PFKFB3 project, which targets the ability of solid tumors, such as breast, prostate, lung, and colon cancer to survive and resist chemotherapy and radiotherapy treatment; and ROR-1 project that aims to develop a targeted drug to treat chronic lymphatic leukemia. The company was founded in 2010 and is based in Solna, Sweden.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KAN:SS kr5.05 SEK +0.05

KAN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for KAN.
View Industry Companies
 

Industry Analysis

KAN

Industry Average

Valuation KAN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 274.7x
Price/Book 15.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 252.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KANCERA AB, please visit www.kancera.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.